Hamps Bio Services IPO subscribed overall 1,057 times on the last day, while A retail quota was subscribed 1,342.04 times, QIB was subscribed 0.00 times, and NII quota subscribed by 758.27 times respectively.
Details About Hamps Bio IPO
Hamps Bio got approval from SEBI for an IPO of ₹6.22 crores to raise funds and maintain financial stability. The face value of each share was Rs 10. Moreover, the company has set up a price band between ₹51 per share. In this IPO total of 2000 shares were available in 1 lot size for the minimum Retail category and for the maximum retail category 2000 shares in 1 lot size, while S-HNI (Min) total of 4000 shares in 2 lot size.
To invest in this IPO, each investor category has specific investment amounts:
- Retail Investors: Minimum investment of ₹102,000 and maximum investment of ₹102,000.
- Small HNI (S-HNI): Minimum investment of ₹204,000.
Subscription duration of Hamps Bio IPO
The opening date of Hamps Bio Services IPO subscription was 13 December and the closing date was 17 December. The Hamps Bio Services IPO allotment was finalized on December 18 and the IPO listing is on December 20.
Funds Deployment of This Company
The company plans to use the money raised from the new shares for the following purposes:
- The company has decided to utilize funds for the purchase of plant & machinery for the FMCG division.
- Using the funds to Enhance the visibility and awareness of the brand.
- Last but not least, the remaining amount will go to the General corporate purposes.
About Hamps Bio Services IPO
Hamps Bio was founded in 2007 and is a famous company in the marketing and distribution of a variety of pharmaceutical products, such as tablets, syrups, capsules, injectables, oil, gel, and powder. They sell freeze-dried and frozen goods such as fruits, vegetables, flowers, and herbs in addition to pharmaceuticals. They are well-known for their pharmaceutical items under the Hamps brand, and their FzyEzy brand is known for its high-quality freeze-dried and frozen goods. Products are sold on e-commerce sites such as Amazon.com, Amazon.ca, and Amazon.eu, Flipkart, Jio Mart, and others. Additionally, Hamps Bio Limited has made ₹647.53 lakh so far this year from the sale of pharmaceutical products in 8 states and Union Territories, generating ₹366.43 lakh in revenue for the Fiscal 2024, and freeze-dried and frozen products in 4 countries and 22 states and Union Territories, generating ₹281.10 lakh revenue.
Hamps Bio Services IPO Financial Background
In Fiscal year 2024, the company reported revenue of ₹108.48 crores against ₹90.36 crores in 2023. In 2024, the company reported a Profit of ₹12.06 crores against Profit of ₹11.42 crores in 2023.
